Craig-Hallum upgrades FormFactor stock rating on earnings potential By Investing.com

Craig-Hallum upgraded FormFactor to Buy from Hold and set a $175 price target, implying upside from the current $132.75 share price. The note follows FormFactor’s Investor Day and updated model, while the company also recently posted Q1 2026 EPS of $0.56 versus $0.44 expected and revenue of $226.1 million versus $203.84 million. Northland and Stifel also raised targets to $118 and $135, respectively, citing strong results and 510 basis points of gross margin expansion quarter-over-quarter.

Analysis

The message to the market is not that AI is structurally broken, but that the near-term monetization path is getting repriced from a “scarcity premium” to a “execution premium.” When investors get more confident in one equipment vendor’s earnings power, the implied message is usually that spending is still healthy but becoming more selective: leading-edge capacity and metrology/content intensity remain funded, while broad-based capex enthusiasm can fade. That tends to favor the pick-and-shovel names with leverage to utilization and process complexity, while leaving the more expensive AI semis vulnerable to any slowdown in order cadence.

NVDA’s negative read-through is subtle: not a fundamental indictment, but a sign that the market is starting to discount any input that could raise the effective cost of AI infrastructure or compress return thresholds. If tax or policy chatter morphs into a broader “AI profitability” debate, high-multiple AI hardware can underperform for weeks even if fundamentals stay intact, because the market will rotate from growth-at-any-price to earnings-quality and supply-chain resilience. The second-order beneficiary is not necessarily the obvious chipmaker, but the suppliers with less customer concentration and better margin durability across cycles.

For FORM, the risk is classic post-upgrade crowding. A stock that has already re-rated sharply can keep working for months if estimate revisions continue, but the asymmetry gets worse once multiple expansion outruns near-term delivery capacity. The main catalyst path is another beat-and-raise cycle plus evidence that advanced-node demand is broadening; the main reversal risk is any guidance pause that suggests customers are normalizing digestion after a multi-quarter acceleration.

The contrarian takeaway is that the best long here may be the supplier with visible earnings revision momentum, while the better short may be the most crowded AI beneficiary if macro/policy noise keeps investors focused on payback periods instead of TAM. This is a dispersion setup, not a clean sector bet.

Key Decisions for Investors

• Long FORM vs short NVDA for 4-8 weeks: expresses relative earnings momentum and supply-chain dispersion while reducing market beta; downside is NVDA-specific upside from a broader AI sentiment rebound.
• Use pullbacks to add to FORM only if the stock holds prior breakout levels over the next 1-2 weeks; risk/reward is favorable while estimate revisions continue, but trim if it starts trading more on multiple expansion than guidance.
• Short-dated NVDA put spreads into any further policy/tax headline-driven strength: best if the market starts treating AI capex as a margin-risk story; risk is rapid squeeze if semis reassert leadership.
• Pair long a diversified semiconductor equipment basket against a basket of high-multiple AI hardware names over the next quarter: captures the move from narrative beta to execution alpha.
• If FORM stalls after the next earnings revision cycle, take profits quickly rather than hold for a long re-rating; the setup is strong, but after a 371% run the convexity shifts fast once expectations plateau.